Two Separate Clusters of SARS-CoV-2 Delta Variant Infections in a Group of 41 Students Travelling from India: An Illustration of the Need for Rigorous Testing and Quarantine
Jan Van Elslande,
Femke Kerckhofs,
Lize Cuypers,
Elke Wollants,
Barney Potter,
Anne Vankeerberghen,
Lien Cattoir,
Astrid Holderbeke,
Sylvie Behillil,
Sarah Gorissen,
Mandy Bloemen,
Jef Arnout,
Marc Van Ranst,
Johan Van Weyenbergh,
Piet Maes,
Guy Baele,
Pieter Vermeersch,
Emmanuel André,
on behalf of the COG-Belgium Consortium
Affiliations
Jan Van Elslande
Clinical Department of Laboratory Medicine and National Reference Center for Respiratory Pathogens, University Hospitals Leuven, BE3000 Leuven, Belgium
Femke Kerckhofs
Clinical Department of Laboratory Medicine and National Reference Center for Respiratory Pathogens, University Hospitals Leuven, BE3000 Leuven, Belgium
Lize Cuypers
Clinical Department of Laboratory Medicine and National Reference Center for Respiratory Pathogens, University Hospitals Leuven, BE3000 Leuven, Belgium
Elke Wollants
Laboratory of Clinical and Epidemiological Virology, Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, BE3000 Leuven, Belgium
Barney Potter
Laboratory of Clinical and Evolutionary Virology, Immunology and Transplantation, Department of Microbiology, Rega Institute, KU Leuven, BE3000 Leuven, Belgium
Anne Vankeerberghen
Laboratory of Clinical Microbiology, OLV Hospital Aalst, BE9300 Aalst, Belgium
Lien Cattoir
Laboratory of Clinical Microbiology, OLV Hospital Aalst, BE9300 Aalst, Belgium
Astrid Holderbeke
Laboratory of Clinical Microbiology, OLV Hospital Aalst, BE9300 Aalst, Belgium
Sylvie Behillil
Institut Pasteur, Molecular Genetics of RNA Viruses, Université de Paris, CNRS UMR 3569, FR75000 Paris, France
Sarah Gorissen
Clinical Department of Laboratory Medicine and National Reference Center for Respiratory Pathogens, University Hospitals Leuven, BE3000 Leuven, Belgium
Mandy Bloemen
Laboratory of Clinical and Epidemiological Virology, Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, BE3000 Leuven, Belgium
Jef Arnout
Biomedical Sciences Group Management, KU Leuven, BE3000 Leuven, Belgium
Marc Van Ranst
Clinical Department of Laboratory Medicine and National Reference Center for Respiratory Pathogens, University Hospitals Leuven, BE3000 Leuven, Belgium
Johan Van Weyenbergh
Laboratory of Clinical Bacteriology and Mycology, Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, BE3000 Leuven, Belgium
Piet Maes
Laboratory of Clinical and Epidemiological Virology, Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, BE3000 Leuven, Belgium
Guy Baele
Laboratory of Clinical and Evolutionary Virology, Immunology and Transplantation, Department of Microbiology, Rega Institute, KU Leuven, BE3000 Leuven, Belgium
Pieter Vermeersch
Clinical Department of Laboratory Medicine and National Reference Center for Respiratory Pathogens, University Hospitals Leuven, BE3000 Leuven, Belgium
Emmanuel André
Clinical Department of Laboratory Medicine and National Reference Center for Respiratory Pathogens, University Hospitals Leuven, BE3000 Leuven, Belgium
We report two clusters of SARS-CoV-2 B.1.617.2 (Delta variant) infections in a group of 41 Indian nursing students who travelled from New Delhi, India, to Belgium via Paris, France. All students tested negative before departure and had a second negative antigen test upon arrival in Paris. Upon arrival in Belgium, the students were quarantined in eight different houses. Four houses remained COVID-free during the 24 days of follow-up, while all 27 residents of the other four houses developed an infection during quarantine, including the four residents who were fully vaccinated and the two residents who were partially vaccinated. Genome sequencing revealed two distinct clusters affecting one and three houses, respectively. In this group of students, vaccination status did not seem to prevent infection nor decrease the viral load. No severe symptoms were reported. Extensive contact tracing and 3 months of nationwide genomic surveillance confirmed that these outbreaks were successfully contained and did not contribute to secondary community transmission in Belgium. These clusters highlight the importance of repeated testing and quarantine measures among travelers coming from countries experiencing a surge of infections, as all infections were detected 6 days or more after arrival.